RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE

Beam Therapeutics Revenue 2024

Beam Therapeutics Revenue

64.68 M USD

Beam Therapeutics Dividend yield

Ticker

BEAM

ISIN

US07373V1052

WKN

A2PY7P

In 2024, Beam Therapeutics's sales reached 64.68 M USD, a -82.87% difference from the 377.71 M USD sales recorded in the previous year.

The Beam Therapeutics Revenue history

YEARREVENUE (undefined USD)GROSS MARGIN (%)
2029e596.49-
2028e239.5-
2027e98.97-
2026e48.84-
2025e65.58-
2024e64.68-
2023377.71-
202260.92-
202151.84-
20200.02-
20190.02-
2018--
2017--

Beam Therapeutics Aktienanalyse

What does Beam Therapeutics do?

Beam Therapeutics Inc. is a leading company in genome editing and was founded in 2018. The company is headquartered in Cambridge, Massachusetts, USA, and aims to develop and bring innovative genome editing technologies to the market. Beam Therapeutics' business model is based on developing groundbreaking technologies that improve and simplify genome editing in living cells. These technologies are used in medicine, agriculture, and other industries to cure diseases, increase crop yields, and improve quality of life. Beam Therapeutics is led by an experienced and competent team composed of leading scientists, engineers, and businesspeople in the industry. The company collaborates closely with industry and academic partners to develop innovative solutions for genome editing. Beam Therapeutics has several business units focused on the development of genome editing technologies and products. One of these business units is the development of CRISPR technologies (Clustered Regularly Interspaced Short Palindromic Repeats), which allow for precise and effective modification of DNA. Beam Therapeutics employs Prime Editors, a new technology that enables the removal, insertion, or replacement of specific DNA sequences. Another important business area for Beam Therapeutics is the development of novel gene therapy products. This involves repairing or removing disease-causing genes in the body to accelerate or even achieve complete recovery. The gene therapy products being developed by Beam Therapeutics have the potential to save lives and provide a long-term solution for certain diseases such as cancer, viral infections, and specific genetic disorders. The company collaborates closely with universities, hospitals, and other institutions to drive the development of gene therapy products. Beam Therapeutics strives to revolutionize the gene therapy industry and improve the treatment of diseases through genome editing. Overall, Beam Therapeutics has an impressive track record and has experienced strong growth in recent years. The company has successfully completed multiple funding rounds to advance its research and development and has hired many talented employees to realize its vision. In summary, Beam Therapeutics is a medical technology company specializing in the development of groundbreaking genome editing technologies and products. The company aims to revolutionize genome editing in medicine, agriculture, and other industries and have a positive impact on people's lives. Beam Therapeutics ist eines der beliebtesten Unternehmen auf Eulerpool.com.

Revenue Details

Understanding Beam Therapeutics's Sales Figures

The sales figures of Beam Therapeutics originate from the total revenue accrued from goods sold or services provided during a specific time period. These numbers are a direct reflection of the company’s ability to translate its products or services into revenue, indicating the demand and market presence.

Year-to-Year Comparison

Analyzing Beam Therapeutics’s yearly sales data offers insights into the company’s growth and stability. An increase in sales suggests a growing demand for its offerings, efficient marketing, or expansion into new markets. Conversely, a decline might indicate market saturation, increased competition, or less effective strategies.

Impact on Investments

Investors often scrutinize Beam Therapeutics's sales data to evaluate its financial health and growth prospects. Consistent sales growth can be a promising indicator of the company’s profitability and potential return on investment, influencing stock prices and investor confidence.

Interpreting Sales Fluctuations

Increases in Beam Therapeutics’s sales indicate market growth, innovation, or effective marketing, often leading to a surge in stock prices. A decline, however, can signal challenges requiring strategic adjustments to enhance market share and profitability.

Frequently Asked Questions about Beam Therapeutics Stock

How much revenue did Beam Therapeutics generate this year?

Beam Therapeutics has achieved a revenue of 64.68 M USD this year.

How much was the turnover of the company Beam Therapeutics compared to the previous year?

The revenue of Beam Therapeutics has increased by -82.87% decreased compared to the previous year.

What does revenue mean for investors?

The revenue of a company is an important indicator of its financial performance and attractiveness for investors.

Which factors influence the revenue of Beam Therapeutics?

The revenue of Beam Therapeutics is influenced by various factors, including the demand for its products and services, market conditions, and prices.

How is the revenue of Beam Therapeutics measured?

Revenue is typically measured in units referring to the sale of goods and services provided by the company.

How does an increase in sales affect investments?

An increase in revenue can prompt investors to invest more money in the company as it serves as a positive signal for its financial performance and growth prospects.

What are the possible risks associated with a declining revenue?

A decline in revenue can prompt investors to invest less money in the company, as it is a negative signal for its financial performance and growth prospects.

Why is the sales revenue of Beam Therapeutics so important for investors?

The revenue of Beam Therapeutics is an important indicator of financial performance and attractiveness for investors.

What strategic measures can a company take to increase revenue?

A company can take various strategic measures to increase revenue, including developing new products and services, introducing new pricing models, and expanding into new markets.

How much dividend does Beam Therapeutics pay?

Over the past 12 months, Beam Therapeutics paid a dividend of . This corresponds to a dividend yield of about . For the coming 12 months, Beam Therapeutics is expected to pay a dividend of 0 USD.

What is the dividend yield of Beam Therapeutics?

The current dividend yield of Beam Therapeutics is .

When does Beam Therapeutics pay dividends?

Beam Therapeutics pays a quarterly dividend. This is distributed in the months of December, March, June, March.

How secure is the dividend of Beam Therapeutics?

Beam Therapeutics paid dividends every year for the past 0 years.

What is the dividend of Beam Therapeutics?

For the upcoming 12 months, dividends amounting to 0 USD are expected. This corresponds to a dividend yield of 0 %.

In which sector is Beam Therapeutics located?

Beam Therapeutics is assigned to the 'Health' sector.

Wann musste ich die Aktien von Beam Therapeutics kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Beam Therapeutics from 3/3/2014 amounting to 0.225 USD, you needed to have the stock in your portfolio before the ex-date on 2/4/2014.

When did Beam Therapeutics pay the last dividend?

The last dividend was paid out on 3/3/2014.

What was the dividend of Beam Therapeutics in the year 2023?

In the year 2023, Beam Therapeutics distributed 0 USD as dividends.

In which currency does Beam Therapeutics pay out the dividend?

The dividends of Beam Therapeutics are distributed in USD.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Beam Therapeutics

Our stock analysis for Beam Therapeutics Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Beam Therapeutics Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.